Okamura Yukiyasu, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Uesaka Katsuhiko
Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
Ann Surg Oncol. 2016 Dec;23(Suppl 5):921-928. doi: 10.1245/s10434-016-5570-z. Epub 2016 Sep 14.
Des-γ-carboxy prothrombin (DCP) is a representative tumor marker of hepatocellular carcinoma (HCC), and its values are occasionally very high in HCC cases. The current study aimed to clarify the postoperative half-life of DCP as a prognostic factor.
This retrospective study enrolled 177 patients who had undergone liver resection as an initial treatment for HCC. Three DCP half-life groups were defined as follows: within the normal range, half-life shorter than 4 days, and half-life of 4 days or longer. The overall and recurrence-free survival rates were estimated and compared among the three groups.
There were 140 patients in the group with a DCP half-life in the normal range, 19 patients in the group with a DCP half-life shorter 4 days, and 18 patients in the group with a DCP half-life of 4 days or longer. A multivariate analysis showed that only a postoperative DCP half-life of 4 days or longer was an independent prognostic risk factor for overall and recurrence-free survival (respective hazard ratios of 2.92 and 4.19; P < 0.001). The group with a preoperative DCP value lower than 1400 mAU/mL, the median value of DCP in the current study, included no patients from the group with a half-life shorter than 4 days. The overall and recurrence-free survival rates in the group with a half-life of 4 days or longer were significantly poorer (P < 0.001) than in the group that had a half-life shorter than 4 days (P = 0.002) with a preoperative DCP status of 1400 mAU/mL or more.
The current study showed for the first time that a prolonged half-life of DCP is an independent prognostic risk factor for survival and recurrence after liver resection with curative intent.
去γ-羧基凝血酶原(DCP)是肝细胞癌(HCC)的代表性肿瘤标志物,其值在HCC病例中偶尔会非常高。本研究旨在阐明DCP作为预后因素的术后半衰期。
本回顾性研究纳入了177例行肝切除术作为HCC初始治疗的患者。三个DCP半衰期组定义如下:正常范围内、半衰期短于4天、半衰期为4天或更长。估计并比较三组的总生存率和无复发生存率。
DCP半衰期在正常范围内的组有140例患者,DCP半衰期短于4天的组有19例患者,DCP半衰期为4天或更长的组有18例患者。多因素分析显示,仅术后DCP半衰期为4天或更长是总生存和无复发生存的独立预后危险因素(各自的风险比为2.92和4.19;P<0.001)。术前DCP值低于本研究中DCP中位数1400 mAU/mL的组中,没有半衰期短于4天组的患者。半衰期为4天或更长的组的总生存率和无复发生存率显著低于(P<0.001)术前DCP状态为1400 mAU/mL或更高且半衰期短于4天的组(P=0.002)。
本研究首次表明,DCP半衰期延长是根治性肝切除术后生存和复发的独立预后危险因素。